Moderna | Kostnadene For Salg



Cost Of Sales Endring Dato
Acadia Pharmaceuticals USD 21.8M 2.95M 2024-12
Adcock Ingram Holdings ZAR 3.29B 163.08M 2024-06
Agios Pharmaceuticals USD 1.26M 477K 2024-12
Alnylam Pharmaceuticals USD 102.82M 16.91M 2024-12
Amgen USD 3.11B 198M 2024-12
Biogen USD 583.5M 55.2M 2024-12
BioMarin Pharmaceutical USD 136.14M 52.32M 2024-12
Celltrion KRW 418.52B 88.39B 2024-09
Cspc Pharmaceutical CNY 2.07B 71.26M 2024-09
Gilead Sciences USD 1.58B 7M 2024-12
GlaxoSmithKline GBP 2.56B 162M 2024-12
Incyte USD 82.38M 2.49M 2024-12
Ionis Pharmaceuticals USD 3.83M 2.76M 2024-12
Kangmei Pharma CNY 1.21B 124.7M 2024-09
Knight Therapeutics CAD 47.25M 990K 2024-09
Laboratorios Farma EUR 67.85M 2.34M 2024-06
Malin Corporation EUR 15.4M 0 2020-12
Moderna USD 546M 246M 2024-12
Organigram Holdings CAD 41.68M 69.31M 2024-12
Pharma Mar EUR 1.31M 696K 2024-12
Qiagen NV USD 187.91M 16.67M 2024-12
Regeneron Pharmaceuticals USD 565.4M 74.3M 2024-12
Sarepta Therapeutics USD 132.3M 40.61M 2024-12
Sartorius EUR 448.5M 23.9M 2024-09
Sino Biopharmaceutical CNY 1.42B 310.98M 2024-06
Tilray USD 149.73M 9.39M 2024-11
Ultragenyx Pharmaceutical USD 16.89M 4.13M 2024-12
United Therapeutics USD 75.9M 7.2M 2024-12
Vertex Pharmaceuticals USD 423.4M 30.8M 2024-12
Zz Pientze Pharmaceu 1.49B 37.2M 2024-09



Moderna Kostnadene For Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.